This requirement is to identify businesses that have the capability and experience to provide cytogenetics specimen testing. Walter Reed Army Medical Center estimates the following annual usage of these specific tests: Chromosome Analysis Bone Marr ow, Genzyme Product code #130, estimated quantity 300; Chromosome Analysis Lymph Node, Solid Tumor, Genzyme Product # 170/171, estimated quantity 12; Fluorescence in Situ Hybridization Panel, Genzyme Product Code #466, estimated quantity 180; B/T Cell Gene Rearrangements PCR, Genzyme Product Code #480/481, estimated quantity 24; BCR/ABL PCR Bone Marrow Genzyme Product Code #156, estimated quantity 24. The North American Industry Classification System (NAICS) code is 621511. . T his requirement, W91YTZ-04-T-0136 is for one base year and four option years. Walter Reed Army Medical Center is located at 6900 Georgia Avenue NW, Washington, DC 20307. All interested parties must be registered in the Central Contractor Register (CCR) in order to receive an award. Furthermore all interested parties must meet all regulatory requirements, i.e. CAP certification, CLIA certification, and FDA licensure. Proof of licensure and/or certifications will be required with solicitation. Interested parties shall provide detailed information on proposed products, which clearly m eet the requirements stated above. Response(s) may be via E-mail or on company letterhead; include company’s name, point of contact, address, phone number, Duns Number, Tax ID, business size. All responses must be received by 20 August 2004. Response s may be faxed to 202-356-0374, or e-mailed to [email protected]. Approved for Electronic Release via Internet

Bid Protests Not Available